Paroxysmal atrial fibrillation prevention by pacing in patients with pacemaker indication.

I. Lozano,A. Vincent,J. Roda,M. Méndez,J. Ferrer,F. Andrade,J. Manzano,R. Ceres,J. Errejon,J. Toquero

DOI: https://doi.org/10.1016/S1099-5129(03)00041-2

2003-07-01

Abstract:

What problem does this paper attempt to address?

Obstetric venous thromboembolism: Evaluation of prophylactic approach based on risk scores, D-dimer levels, and ultrasonography findings in a tertiary hospital in Japan

Mana Obata-Yasuoka,Rena Ohara,Yoshihiko Hosokawa,Keiko Nishida,Haruna Abe,Miyuki Mayumi,Tomoko Ishizu,Naho Endo-Kawamura,Hiromi Hamada,Toyomi Satoh

DOI: https://doi.org/10.1111/jog.15332

Abstract:Aim: Pulmonary embolism remains a leading cause of maternal mortality in developed countries despite developments in venous thromboembolism prophylaxis strategies. This study aimed to evaluate the effectiveness of our approach involving risk-scoring, D-dimer level assessment, and ultrasonography for obstetric venous thromboembolism. Methods: This retrospective cohort study included women who delivered at 22-41 weeks of gestation in The University of Tsukuba Hospital, Japan between January and December 2020. Venous thromboembolism risk (determined according to Japanese guidelines) and D-dimer levels were evaluated within 20 weeks of gestation, 30-34 weeks of gestation, and during the pre-delivery period (36 weeks of gestation or any time before preterm delivery). Compression and color Doppler ultrasonography for lower extremity deep vein thrombosis were performed if D-dimer levels were ≥3.2 μg/mL (for those undergoing cesarean delivery, 1.0 μg/mL). Results: Of 1026 women, 6 women had deep vein thrombosis during pregnancy and 1 during the puerperium period. Pulmonary embolism was not observed. The D-dimer screening result was positive for 8 women (2%) within 20 weeks of gestation (deep vein thrombosis was confirmed in 3 of them), 87 women (10%) (no deep vein thrombosis) at 30-34 weeks of gestation, and 367 women (36%) during the pre-delivery period (asymptomatic deep vein thrombosis in one). Based on the Japanese guidelines, 1%, 11%, 33%, and 55% of women had high, intermediate, low, and no postpartum risk factors, respectively. Conclusions: Our approach appears useful for antenatal venous thromboembolism screening in the first trimester. For postpartum prophylaxis, more cost-effective strategies are needed.
Epidemiology, natural history, diagnosis, and management of ovarian vein thrombosis: a scoping review

Margaux Monnet,Virginie Dufrost,Denis Wahl,Olivier Morel,Mikaël Agopiantz,Stéphane Zuily

DOI: https://doi.org/10.1016/j.jtha.2024.07.033

2024-08-27

Abstract:Ovarian vein thrombosis (OVT) is a rare but potentially serious condition. We conducted a scoping review of published data to provide a better understanding of OVT management. MEDLINE and Cochrane databases were searched. Eligibility criterion was original articles including women with OVT until May 2024. Quantitative data were pooled via CMA software. Quality of the primary studies was assessed via the Newcastle‒Ottawa Scale. Out of 1,007 identified records, 19 primary studies including 1,128 patients were selected. Mean age at OVT diagnosis was 37 years old. Frequency of OVT depended on the clinical situation: cancer (37%) and postpartum (0.06%), including cesarean (0.19%), or persistent fever despite antibiotics (23%). Magnetic resonance imaging was associated with the best diagnostic performance, followed by computed tomography. Pulmonary embolism and extension to the iliac vein, inferior vena cava or left renal vein occurred in 6.5%, 5.9%, 10.3% and 9.6% of patients, respectively. Among anticoagulants, low-molecular-height heparin with/without oral anticoagulant was preferred for three to six months. Among the women tested, thrombophilia was present in 18% of the patients. Recanalization, recurrent thrombosis or major bleeding occurred in 70%, 8% and 2% of patients, respectively. Majority of studies had poor evidence. This scoping review provides a comprehensive evaluation of available data. Frequency of OVT depends on the clinical setting. Physicians should be aware of OVT in postpartum women with persistent fever despite the use of antibiotics. Ovarian vein thrombosis belongs to the spectrum of venous thromboembolism and should be considered both in puerperal settings and in cancer patients.
Ovarian vein thrombosis in a postpartum female: A case report

Anamika Jha,Abhikanta Khatiwada,Sharada Kc

DOI: https://doi.org/10.1016/j.radcr.2024.07.063

2024-08-10

Abstract:Ovarian vein thrombosis (OVT), while uncommon, is a serious complication that can arise from pregnancy, pelvic inflammatory disease, oncological conditions, and pelvic surgeries. Here we discuss a case of a 37-year-old woman who, during her postpartum period, experienced lower abdominal pain and fever. Utilizing imaging findings, she was ultimately diagnosed with right ovarian vein thrombosis. The puerperium represents a hypercoagulable state, heightening the risk of OVT, particularly following a cesarean section. Despite its rarity, OVT should invariably be considered in the differential diagnosis when evaluating patients who present with postpartum abdominal pain and/or fever.
Thrombotic pulmonary embolism of inferior vena cava during caesarean section: A case report and review of the literature

Lan Jiang,Wei-Xiang Liang,Yi Yan,Shou-Ping Wang,Li Dai,Dun-Jin Chen

DOI: https://doi.org/10.12998/wjcc.v10.i13.4226

2022-05-06

World Journal of Clinical Cases

Abstract:BACKGROUND: Thrombotic pulmonary embolism (TPE) is one of the most critical diseases in obstetrics but is rarely reported in caesarean section (CS) because TPE patients in CS have a high risk of death and are difficult to diagnose. This case report of TPE during CS was recorded by transthoracic echocardiography (TTE) and can provide a reference for the differential diagnosis of critical illnesses in CS.CASE SUMMARY: A 37-year-old pregnant woman with rheumatic heart disease (RHD), gravida 5 and para 1 (G5P1), presented for emergency CS at 33 wk and 3 d of gestation under general anesthesia because of acute heart failure, pulmonary hypertension and arrhythmia. After placental removal during CS, TTE revealed a nascent thrombus in the inferior vena cava (IVC) that elongated, detached and fragmented leading to acute thromboembolic events and acute TPE. This report presents the whole process and details of TPE during CS and successful rescue without any sequelae in the patient. This case gives us new ideas for the diagnosis of death or cardiovascular accidents during CS in pregnant women with heart disease and the detailed presentation of the rapid development of TPE may also elucidate new ideas for treatment. This case also highlighted the importance of prophylactic anticoagulation in the management of heart disease during pregnancy.CONCLUSION: Pregnancy with heart failure could trigger inferior vena cava (IVC)-origin TPE during CS. Detection and timely treatment can avoid serious consequences.

medicine, general & internal
VTE Risk Assessment and Prevention in Pregnancy

Ellen O'Rourke,Rehman Faryal,Marc Blondon,Saskia Middeldorp,Fionnuala Ní Áinle,Ní Áinle,Fionnuala

DOI: https://doi.org/10.1055/a-2238-4681

2024-02-28

Hämostaseologie

Abstract:Venous thromboembolism (VTE) remains the leading cause of maternal mortality in pregnancy and the postpartum period. In addition to the higher pregnancy-associated baseline VTE risk, there are several well-established risk factors that can further increase the risk of VTE. At present, a thorough interrogation of these risk factors remains our only tool for estimating which pregnant people may be at an increased risk of VTE, and thus potentially benefit from thromboprophylaxis. However, an important knowledge gap still exists surrounding the duration of increased risk and the interaction of risk factors with each other. Furthermore, up to now, once significant risk has been established, prevention strategies have been largely based on expert opinion rather than high-quality data. Recent trials have successfully bridged a proportion of this knowledge gap; however, the challenge of conducting high-quality clinical trials with pregnant people remains. In this article, we provide an update on the recent evidence surrounding VTE risk factors in pregnancy while concurrently outlining knowledge gaps and current approaches to VTE prevention. Received: 07 September 2023 Accepted: 02 January 2024 Article published online: 26 February 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

hematology
Rare deep vein thrombosis in pregnancy and puerperium 3 case series; upper extremities vein thrombosis, ovarian vein thrombosis, portal and superior mesenteric vein thrombosis

Eun Duc Na,Ji Yoon Kim,Ji Yeon Lee,Sang Hee Jung,Young Ran Kim,Ji Hyon Jang

DOI: https://doi.org/10.1111/jog.15890

2024-01-15

Journal of Obstetrics and Gynaecology Research

Abstract:Pregnancy induces a hypercoagulable state, elevating thrombosis risk by 5–6 times compared to non‐pregnant conditions. Predominantly affecting the left lower extremity due to anatomical and hematological factors, deep vein thrombosis can escalate into pulmonary embolism, impacting mortality. The authors aim to report rare incidents of thrombosis beyond the norm, including upper extremity vein thrombosis, right ovarian vein thrombosis, and portal vein and superior mesenteric vein thrombosis, highlighting their significance. Obstetricians should be mindful that thrombosis can occur not only in the lower extremities but also in other areas. Especially when symptoms such as fever unresponsive to antibiotics, atypical pain, and an abnormally high C‐reactive protein level are present. Considering the possibility of a rare thrombosis is crucial. Understanding these less common thrombotic events during pregnancy and the postpartum period can contribute to the improvement of timely diagnosis and management strategies.

obstetrics & gynecology
Posterior epidural migration of lumbar disk fragments: report of two cases and review of the literature.

A. C. El Asri,O. Naama,A. Akhaddar,M. Gazzaz,A. Belhachmi,B. El mostarchid,M. Boucetta

DOI: https://doi.org/10.1016/j.surneu.2007.06.034

2008-12-01

Surgical Neurology

Abstract:
Venous Thromboembolism in Pregnancy: A Review of Diagnosis, Management, and Prevention

Katherine Kilkenny,William Frishman

DOI: https://doi.org/10.1097/crd.0000000000000756

2024-07-25

Cardiology in Review

Abstract:Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism, is a leading cause of maternal morbidity and mortality worldwide. Physiological changes that occur in a normal pregnancy increase the risk for VTE by 4–5-fold in the antepartum period and 30–60-fold in the immediate postpartum period. Compressive ultrasonography is the diagnostic test of choice for deep vein thrombosis. Both ventilation/perfusion scanning and computed tomography pulmonary angiography can reliably diagnose pulmonary embolism. Anticoagulation for a minimum of 3 months, typically with low molecular weight heparin, is the treatment of choice for pregnancy-associated VTE (PA-VTE). Despite the significant societal burden and potentially devastating consequences, there is a paucity of data surrounding the prevention of PA-VTE, resulting in major variations between international guidelines. This review will summarize the current recommendations for diagnosis, management, and prevention of PA-VTE.

cardiac & cardiovascular systems
Venous Thromboembolism Prophylaxis in Obstetric Patients

Emma L Klaserner,Kayla J Popova,Rikki-Leigh Gaudet

DOI: https://doi.org/10.1177/08971900241247628

Abstract:Venous thromboembolism (VTE), including both pulmonary embolism (PE) and deep vein thrombosis (DVT), is the leading cause of maternal death in developed countries. Pregnancy is associated with an increased risk of VTE due to physiologic changes during the obstetric period that promote a hypercoagulable state. Appropriate use of prophylactic anticoagulants can decrease the event rate of thrombus formation in at-risk patients. In the United States, there is not a validated risk-assessment tool for VTE in obstetric patients or a clear consensus on initiation and optimal dosing strategy for the prophylactic use of anticoagulants. This article reviews the mechanism of coagulation disturbance that leads to an increased risk of VTE in obstetric patients, as well as the available literature surrounding pharmacologic prophylaxis.
Postpartum septic pelvic thrombophlebitis and ovarian vein thrombosis after caesarean section: a rare case report

Qin Shi,Deborah Shulamite Gandi,Yurong Hua,Yi Zhu,Jinhan Yao,Xiaoqing Yang,Yunzhao Xu,Yuquan Zhang

DOI: https://doi.org/10.1186/s12884-021-04037-4

2021-08-17

BMC Pregnancy and Childbirth

Abstract:Abstract Background Septic pelvic thrombophlebitis (SPT) is a well-recognized but rare puerperal complication that has two types: ovarian vein thrombophlebitis (OVT) and deep septic pelvic thrombophlebitis (DSPT). The present case report describes the clinical and imaging findings of a female patient diagnosed with right ovarian vein infectious thrombophlebitis after caesarean section (C-section). Case presentation A 35-year-old G3P2 female who presented with a foetal vein Galen malformation at 41 weeks of gestation underwent C-section. The patient had high fever after C-section, and anti-inflammatory treatment was not effective within 1 week. An abdominal wall incision haematoma was found, and a second surgery for the removal of the abdominal wall haematoma was performed. The patient was ultimately diagnosed with abdominal incision haematoma and right ovarian vein infectious thrombophlebitis after C-section. We used imipenem and tigecycline to strengthen the anti-inflammatory effects, simultaneously administrating low-molecular-weight heparin and warfarin as anticoagulant therapy. On the 30th day after C-section, the right ovarian vein thrombus disappeared. Conclusion This case illustrates the need to consider the potential relationship between abdominal incision haematoma and ovarian vein thrombophlebitis. Despite advances in the management of venous thromboembolism globally, more data on epidemiology in terms of first incidence, prevalence, recurrence and risk factors, management of bleeding complications, and increased awareness in Asian populations are necessary.

obstetrics & gynecology
Venous Thromboembolism and Ovarian Torsion-detorsion in Pregnancy: a Case Report and Systematic Review of the Literature&nbsp;

Peng Zhao,Ying Zhao,Quan Zhang,Zhu Zhou,Jianhong Zhou,Fei Ruan

DOI: https://doi.org/10.21203/rs.3.rs-114658/v1

2020-01-01

Abstract:Abstract The safety of adnexal detorsion in pregnant women is debatable as the hypercoagulable state during pregnancy intensifies the risk of thromboembolism. The diagnosis and treatment is challenging because its rarity and complexity due to the foetal health. Here we presented a rare case of venous thromboembolism (VTE) after ovarian detorsion during early pregnancy and conducted a review of the literature. VTE after ovarian torsion-detorsion in pregnancy is an infrequent event and is more likely to occur in the first and second trimester. The diagnosis depends mainly on the clinical manifestation, D-dimer level and imaging tests such as compression ultrasonography and computed tomography pulmonary angiogram. Low-molecular-weight heparin remains the drug of choice for both prophylactic measurement and therapeutic strategy. With prompt diagnosis and immediate treatment, VTE after ovarian torsion-detorsion is usually uneventful.
Long-Term Outcome of Catheter-Directed Thrombolysis in Pregnancy-Related Venous Thrombosis

Xiaolong Du,Hao Zhuang,Lei Hong,Yeqing Zhang,Chengtong Li,Aimin Qian,Hongfei Sang,Xiaoqiang Li

DOI: https://doi.org/10.12659/msm.914592

2019-01-01

Medical Science Monitor

Abstract:BACKGROUND Venous thromboembolism (VT) is a leading cause of maternal mortality and morbidity worldwide. Catheter-directed thrombolysis (CDT) is an effective and safe treatment modality for VT patients. However, the long-term outcome of CDT in pregnancy-related venous thrombosis are unclear. The aim of this study was to assess long-term results of pregnancy-related VT patients. MATERIAL AND METHODS We reviewed 41 pregnancy-related deep venous thrombosis (DVT) patients who underwent CDT from February 2008 to May 2015. Clinical data, including demographic variables, disease location, vascular risk factors, treatment regimen, interventional procedure and complications, were collected retrospectively. Clinical and color-duplex ultrasonography were performed to monitor venous patency during follow-up. Post-thrombotic syndrome (PTS) was assessed with the Villalta scale and quality of life (QOL) was evaluated by the VEINES-QOL/Sym questionnaire. RESULTS Twenty-three patients underwent spontaneous abortion or induced abortion within 3 months before DVT, and 18 patients had DVT during the first 3 months after delivery. Technical success was achieved in all patients. Grade III (complete) lysis was obtained in 15 patients and grade II (partial) lysis was obtained in 21 patients. The follow-up period was 3 years. Twenty-eight patients had venous patency at 3-year follow-up; 36.6% of patients developed mild or moderate PTS (Villalta score 5-14) and 4.8% with severe PTS (Villalta score ≥15). VEINES-QOL/Sym scores were 55.24±7.35 and 53.25±6.65, respectively. CONCLUSIONS Catheter-directed thrombolysis is a reliable and safe treatment modality for postnatal or abortion patients with DVT. CDT can reduce the incidence rate of PTS and increase the quality of life.
Venous Thromboembolism and Ovarian Torsion-detorsion in Pregnancy: a Case Report and Systematic Review of the Literature 

Peng Zhao,Ying Zhao,Quan Zhang,Zhou Zhu,Jianhong Zhou,Fei Ruan

DOI: https://doi.org/10.21203/rs.3.rs-114658/v1

2020-01-01

Abstract:Abstract The safety of adnexal detorsion in pregnant women is debatable as the hypercoagulable state during pregnancy intensifies the risk of thromboembolism. The diagnosis and treatment is challenging because its rarity and complexity due to the foetal health. Here we presented a rare case of venous thromboembolism (VTE) after ovarian detorsion during early pregnancy and conducted a review of the literature. VTE after ovarian torsion-detorsion in pregnancy is an infrequent event and is more likely to occur in the first and second trimester. The diagnosis depends mainly on the clinical manifestation, D-dimer level and imaging tests such as compression ultrasonography and computed tomography pulmonary angiogram. Low-molecular-weight heparin remains the drug of choice for both prophylactic measurement and therapeutic strategy. With prompt diagnosis and immediate treatment, VTE after ovarian torsion-detorsion is usually uneventful.
Postoperative Pulmonary Embolism Including Asymptomatic Cases in Gynecologic Oncology

Masao Okadome,Toshiaki Saito,Daisuke Miyahara,Takeharu Yamanaka,Toshiro Kuroiwa,Yujiro Kurihara

DOI: https://doi.org/10.1111/igc.0b013e3181bdbeb5

2010-05-01

International Journal of Gynecological Cancer

Abstract:INTRODUCTION: So far, there has been no report addressing the actual rate of asymptomatic pulmonary embolism (PE). The present study was conducted to clarify the incidence and the characteristics of postoperative PE including asymptomatic cases in gynecologic oncology.METHODS: A total of 2107 gynecologic surgery cases that were performed from January 1996 to December 2006 at the National Kyushu Cancer Center were included. Pulmonary embolism was diagnosed using a lung scan, multi-detector row computed tomography, or pulmonary angiography. The clinical factors, including prophylaxis, were analyzed by univariate and multivariate analyses.RESULTS: PE was diagnosed in 45 patients (2.14%). Six (13.3%) of the 45 patients had respiratory symptoms or signs, and 16 patients (35.6%) had no symptoms or signs except for a SpO2 level decrease. PE was diagnosed within 4 days after the surgery in 42 patients (93.3%). There were 1 massive, 2 recurrent, and no fatal PEs. A multivariate analysis demonstrated the incidence of PE to be associated with age (odds ratio, 1.957; 95% confidence interval, 1.497-2.559), operation time (1.664; 1.180-2.346), body mass index (2.457; 1.735-3.479), surgical position (2.253; 1.468-3.458), and the use of a perioperative intermittent pneumatic compression device (0.389; 0.229-0.659).CONCLUSIONS: A substantial number of postoperative PEs were occult, and identification of high-risk patients and routine SpO2 level monitoring would reduce the diagnostic delay of PE after gynecologic surgery. Increasing age, longer operation time, and obesity were risks. The use of a perioperative intermittent pneumatic compression device in multimodal conditions might thus prevent PE.

oncology,obstetrics & gynecology
Diagnosis and management of treatment‐related osteoporosis in men with prostate carcinoma

Matthew R. Smith

DOI: https://doi.org/10.1002/cncr.11149

IF: 6.9209

2003-02-01

Cancer

Abstract:Osteoporosis is a complication of androgen deprivation therapy in men with prostate carcinoma. Androgen deprivation therapy, caused by either bilateral orchiectomy or treatment with a gonadotropin‐releasing hormone agonist, decreases bone mineral density and increases fracture risk. Other factors including diet and lifestyle may contribute to bone loss. There is limited information regarding the best strategy to prevent osteoporosis in men with prostate carcinoma. Lifestyle modification including smoking cessation, moderation of alcohol consumption, and regular weight‐bearing exercise should be encouraged. Supplemental calcium and vitamin D are also recommended. Additional treatment may be warranted for men with osteoporosis, fractures, or high rates of bone loss during androgen deprivation therapy. Intravenous pamidronate, a second‐generation bisphosphonate, prevents bone loss during androgen deprivation therapy. Zoledronic acid, a more potent third‐generation bisphosphonate, not only prevents bone loss but also increases bone mineral density during androgen deprivation therapy. Other bisphosphonates may be effective although they have not been evaluated in this clinical setting. Treatment with estrogens or selective estrogen receptor modulators may also be effective. Monotherapy with bicalutamide or other antiandrogens may cause less bone loss than androgen deprivation therapy. Cancer 2003;97(3 Suppl):789–95. © 2003 American Cancer Society.
Examining postpartum anticoagulation practices: An international survey of healthcare providers

Evangelia Vlachodimitropoulou,Marc Carrier,Kinga Malinowski,Adam Cuker,Eric Kaplovitch,Nadine Shehata

DOI: https://doi.org/10.1016/j.thromres.2024.109113

Abstract:Background: The risk of venous thromboembolism (VTE) is 15 to 35-fold higher in the postpartum period compared to non-pregnant individuals. Clinical practice guidelines recommend the use of postpartum thromboprophylaxis with low molecular weight heparin (LMWH) for 6 weeks in individuals at high risk of developing VTE. However, a marked reduction in the risk of VTE risk occurs beyond the third week of the postpartum period. Objective: We sought to characterize practice patterns of clinicians who manage postpartum individuals at high risk of VTE. Methods: We conducted a cross-sectional study using a self-administered electronic questionnaire. The survey explored the use of postpartum thromboprophylaxis in high-risk individuals. Descriptive statistics were used to summarize survey responses. Results: Of the 113 participants that responded to the initial invitation, 78 completed the survey (Europe (53.9 %); North America (23.2 %); Australia and New Zealand (19.0 %)). For individuals with a prior unprovoked or provoked deep venous thrombosis or pulmonary embolism, cerebral vein thrombosis and splanchnic vein thrombosis, 97.4 %, 93.5 %, 91.0 % and 88.5 % of the respondents recommended six weeks of postpartum thromboprophylaxis using LMWH, respectively. The recommendation for 6 weeks of thromboprophylaxis in patients with sickle cell disease and obstetric APS was comparatively lower (70.5 and 78.2 % respectively). Respondents with higher practice volumes and more years of experience in clinical practice were more likely to recommend a shorter duration of thromboprophylaxis. Conclusion: Our study highlights the variability in clinician recommendations and the acceptability of treatment durations for postpartum thromboprophylaxis in high-risk conditions. Prospective studies are needed to determine optimal duration and establish evidence-based management.
VTE risk assessment, prevention and diagnosis in pregnancy

Ahmed Lutfi,Ellen O'Rourke,Maeve Crowley,Eilidh Craig,Amy Worrall,Barry Kevane,Fergal O'Shaughnessy,Jennifer Donnelly,Brian Cleary,Fionnuala Ní Áinle

DOI: https://doi.org/10.1016/j.thromres.2024.01.025

IF: 10.407

2024-02-04

Thrombosis Research

Abstract:Venous thromboembolism (VTE) is still reported as the leading cause of direct maternal death in pregnancy in serial international reports in developed countries. VTE risk is higher during pregnancy but is further increased by additional well-characterized risk factors. International guidelines recommend that formal VTE risk assessment should be conducted at least in early pregnancy, at delivery and when risk factors change. High quality data supporting optimal VTE prevention strategies are lacking, outside the setting of prevention of VTE recurrence. Moreover, recent high-quality studies have provided much-needed data on diagnostic strategies for pulmonary embolism (PE) in pregnancy. In this review, we summarize knowledge gaps and recently published data in the prevention and diagnosis of VTE in pregnancy. Moreover, we describe ongoing high-quality randomised trials and prospective clinical management studies in this area. High quality clinical studies and trials in pregnancy can be done and must be prioritised, through international network efforts and national funding advocacy. Ultimately, translation of study results to impact upon guidelines and policy will deliver better care to and will protect the lives and health of pregnant people and those contemplating pregnancy throughout the world.

peripheral vascular disease,hematology
Pregnancy-Associated Venous Thromboembolism

Omar Seyam,William H. Frishman,Wilbert S. Aronow

DOI: https://doi.org/10.1097/crd.0000000000000700

2024-04-26

Cardiology in Review

Abstract:One of the leading causes of maternal death in the United States is venous thromboembolism (VTE), which is influenced by acquired, genetic, and environmental factors. Pregnancy-associated physiological changes that exhibit the characteristics of Virchow’s triad: reduced fibrinolysis, increased coagulation factors, trauma, and venous stasis all raise the risk of VTE. Furthermore, multiple gestations, advanced maternal age, cesarean delivery, and obesity are all pregnancy-associated risk factors that also increase the risk of VTE. Management of VTE during pregnancy can be challenging due to the risks and benefits of anticoagulant therapy and potential hazard for both the fetus and the mother. In this review, we discuss the prevalence, pathogenesis, predisposing factors, and therapeutic options such as systemic thrombolysis, mechanical thrombectomy, and catheter-directed thrombolysis.

cardiac & cardiovascular systems
Clinical Characteristics and Management of Asymptomatic Thromboembolism in Psychiatric Inpatients: A Retrospective Study

Peifen Zhang,Hongli Qi,Huimin Huang,Xingle Gao,Lingling Wu,Jianbo Lai,Shaohua Hu

DOI: https://doi.org/10.21203/rs.3.rs-577350/v1

2021-01-01

Abstract:Abstract Background: Venous thromboembolism (VTE) is a severe, life-threatening physical condition. However, the risk of developing VTE in patients with mental disorders has been insufficiently recognized.Methods: In this descriptive study, we retrospectively screened the hospital electronic medical record system and identified the asymptomatic VTE condition in hospitalized patients in the Mental Health Center, First Affiliated Hospital, Zhejiang University School of Medicine from January 2014 to January 2021. The diagnosis of VTE was made based on elevated plasma D-dimer levels and positive imaging findings, including arteriovenous color doppler ultrasonograpny of lower limbs and computed tomography angiography of pulmonary artery. For patients included, demographic and clinical profiles, and findings of laboratory and imaging examinations were collected. The anticoagulant therapy and clinical outcomes of these patients were also recorded.Results: A total of 8093 hospitalized patients were screened and eventually 24 psychiatric patients with asymptomatic VTE were included in the final analysis. The mean age of patients was 65.75±8.69 years old, with 20 patients (83.3%) older than 60 years. 18 (75%) patients were female and 6 (25%) were male. The number of patients with a history of smoking and previous pharmacotherapy was 3 and 19, respectively. And the average BMI of all subjects was 22.85±3.97, which was within the normal values. The average course of psychiatric disorders prior to the hospitalization was 9.15±10.38 years, the mean hospital stays were 23.17±9.14 days and the shortest hospital stay was 10 days. The average plasma levels of D-dimer before anticoagulant therapy was 4060.00±2824.88 ug/L FEU with a range of 920~10700 ug/L FEU (the normal range: 0~700 ug/L FEU). Following anticoagulant therapy, 83.3% (n=20) patients had a significant reduction in the plasma levels of D-dimer and the average reduced to 1678.25 ±1970.16 ug/L FEU, with a minimum level of 160 ug/L FEU. The plasma D-dimer levels between before and after anticoagulant treatment was significantly different (P＜0.05).Conclusion: Our data suggest the necessity screening the asymptomatic VTE among psychiatric patients, especially in those with advanced age, long duration of illness, and female with a long history of psychotropic treatment and high plasma levels of D-dimer. Once the diagnosis of asymptomatic VTE is confirmed, antithrombotic therapy should be initiated as early as possible to avoid fatal consequences.
Venous thromboembolism during pregnancy and postpartum period: an updated review

Sanaullah Mojaddedi,Javairia Jamil,Andrew Abraham,Dawood Jamil,Hend Mansoor,Islam Y Elgendy

DOI: https://doi.org/10.23736/S0026-4806.24.09242-5

2024-10-11

Abstract:Venous thromboembolism (VTE) is a leading cause of maternal mortality. The risk of VTE in pregnant and postpartum women is ~ five times higher compared with non-pregnant women. There is a physiological tendency to a hypercoagulable state, from conception to the postpartum period. Several non-obstetric risk factors independently increase the risk of VTE. Since most signs and symptoms of VTE might mimic those of a normal pregnancy, a high index of suspicion is warranted to establish the diagnosis. D-dimer, ultrasonography and computed tomography pulmonary angiography are the primary tools for VTE diagnosis. Management mainly revolves around systemic anticoagulation with heparin. Advanced therapy options exist, but these can be considered for selected high-risk cases.

Paroxysmal atrial fibrillation prevention by pacing in patients with pacemaker indication.

Obstetric venous thromboembolism: Evaluation of prophylactic approach based on risk scores, D-dimer levels, and ultrasonography findings in a tertiary hospital in Japan

Epidemiology, natural history, diagnosis, and management of ovarian vein thrombosis: a scoping review

Ovarian vein thrombosis in a postpartum female: A case report

Thrombotic pulmonary embolism of inferior vena cava during caesarean section: A case report and review of the literature

VTE Risk Assessment and Prevention in Pregnancy

Rare deep vein thrombosis in pregnancy and puerperium 3 case series; upper extremities vein thrombosis, ovarian vein thrombosis, portal and superior mesenteric vein thrombosis

Posterior epidural migration of lumbar disk fragments: report of two cases and review of the literature.

Venous Thromboembolism in Pregnancy: A Review of Diagnosis, Management, and Prevention

Venous Thromboembolism Prophylaxis in Obstetric Patients

Postpartum septic pelvic thrombophlebitis and ovarian vein thrombosis after caesarean section: a rare case report

Venous Thromboembolism and Ovarian Torsion-detorsion in Pregnancy: a Case Report and Systematic Review of the Literature&amp;nbsp;

Long-Term Outcome of Catheter-Directed Thrombolysis in Pregnancy-Related Venous Thrombosis

Venous Thromboembolism and Ovarian Torsion-detorsion in Pregnancy: a Case Report and Systematic Review of the Literature&nbsp;

Postoperative Pulmonary Embolism Including Asymptomatic Cases in Gynecologic Oncology

Diagnosis and management of treatment‐related osteoporosis in men with prostate carcinoma

Examining postpartum anticoagulation practices: An international survey of healthcare providers

VTE risk assessment, prevention and diagnosis in pregnancy

Pregnancy-Associated Venous Thromboembolism

Clinical Characteristics and Management of Asymptomatic Thromboembolism in Psychiatric Inpatients: A Retrospective Study

Venous thromboembolism during pregnancy and postpartum period: an updated review

Venous Thromboembolism and Ovarian Torsion-detorsion in Pregnancy: a Case Report and Systematic Review of the Literature 

Venous Thromboembolism and Ovarian Torsion-detorsion in Pregnancy: a Case Report and Systematic Review of the Literature